BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang S, Zhou X, Zeng Z, Sui M, Chen L, Feng C, Huang C, Yang Q, Ji M, Hou P. Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment. J Nanobiotechnology 2021;19:302. [PMID: 34600560 DOI: 10.1186/s12951-021-01034-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Z, Liu Y, Song W, Jiang X, Deng Z, Xiong W, Shen J. Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy. Journal of Controlled Release 2022;352:793-812. [DOI: 10.1016/j.jconrel.2022.11.004] [Reference Citation Analysis]
2 Zheng C, Luo W, Liu Y, Chen J, Deng H, Zhou Z, Shen J. Killing Three Birds with One Stone: Multi-stage Metabolic Regulation Mediated by Clinically Usable Berberine Liposome to Overcome Photodynamic Immunotherapy Resistance. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.140164] [Reference Citation Analysis]
3 Jiang M, Qin B, Li X, Liu Y, Guan G, You J. New advances in pharmaceutical strategies for sensitizing anti‐PD ‐1 immunotherapy and clinical research. WIREs Nanomed Nanobiotechnol 2022. [DOI: 10.1002/wnan.1837] [Reference Citation Analysis]
4 Acharya S, Misra R. Hypoxia responsive phytonanotheranostics: A novel paradigm towards fighting cancer. Nanomedicine: Nanotechnology, Biology and Medicine 2022;42:102549. [DOI: 10.1016/j.nano.2022.102549] [Reference Citation Analysis]
5 Liu Y, Xu D, Liu Y, Zheng X, Zang J, Ye W, Zhao Y, He R, Ruan S, Zhang T, Dong H, Li Y, Li Y. Remotely boosting hyaluronidase activity to normalize the hypoxic immunosuppressive tumor microenvironment for photothermal immunotherapy. Biomaterials 2022;284:121516. [DOI: 10.1016/j.biomaterials.2022.121516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Gao W, Zhang J, Wang W, Liu Z, Chen M, Hu X, Zeng L, Zheng C, Song H, Zhang Q. Drug Self-delivery Nanorods Enhance Photodynamic Therapy of Triple-Negative Breast Cancer by inhibiting Oxidative Phosphorylation. Int J Pharm 2022;:121775. [PMID: 35489603 DOI: 10.1016/j.ijpharm.2022.121775] [Reference Citation Analysis]
7 Mudassar F, Shen H, Cook KM, Hau E. Improving the synergistic combination of programmed death‐1/programmed death ligand‐1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment. J Med Imag Rad Onc. [DOI: 10.1111/1754-9485.13416] [Reference Citation Analysis]